Crohn’s Research Awarded $400,000 SPARC Grant

Crohn’s Research Awarded $400,000 SPARC Grant
The Strategic Pharma-Academic Research Consortium (SPARC) for Translational Medicine has awarded its first grants, totaling more than $1.9 million, which will be invested to accelerate investigations into autoimmune conditions. Among the five winners is Gwendalyn Randolph, a professor at Washington University in St. Louis, who was awarded a grant to advance research on Crohn's disease. In addition, a SPARC grant was also awarded for research into intestinal fibrosis being conducted by Randolph in collaboration with Razvan Arsenescu, MD, PhD, an associate professor of internal medicine at The Ohio State University. The two investigators will study the condition, which is often a complication of Crohn's disease and may require surgical treatment. The team, which was chosen by an independent governance council that included representatives of all members of the consortium, will be awarded $400,000 over two years. The grant will be used to accelerate the research projects and help translate their lab findings into novel treatments for a disease that affects approximately 700,000 people in the Unites States alone, as noted by the consortium in a press release. SPARC for Translational Medicine aims to support translational research across the Midwest and help connect the power of public and private sectors. The consortium unites collaborations of large-scale translational medicine projects to other needed expertise in order transform medical findings into effective treatments. "There's a true
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *